# Swedish Drug-elution Trial in Peripheral Arterial Disease

> **NCT02051088** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Sahlgrenska University Hospital** · enrollment: 3556 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Critical Limb Ischemia
- Intermittent Claudication

## Interventions

- **PROCEDURE:** Revascularization with drug-eluting technology
- **PROCEDURE:** Revascularization without drug-eluting technology
- **DEVICE:** drug-coated balloons and/or drug-eluting stents

## Key facts

- **NCT ID:** NCT02051088
- **Lead sponsor:** Sahlgrenska University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-11
- **Primary completion:** 2025-04-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 3556 (ACTUAL)
- **Last updated:** 2025-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02051088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02051088, "Swedish Drug-elution Trial in Peripheral Arterial Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02051088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*